AU642592B2 - Carbamates of rapamycin - Google Patents

Carbamates of rapamycin Download PDF

Info

Publication number
AU642592B2
AU642592B2 AU14880/92A AU1488092A AU642592B2 AU 642592 B2 AU642592 B2 AU 642592B2 AU 14880/92 A AU14880/92 A AU 14880/92A AU 1488092 A AU1488092 A AU 1488092A AU 642592 B2 AU642592 B2 AU 642592B2
Authority
AU
Australia
Prior art keywords
rapamycin
carbon atoms
group
ester
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU14880/92A
Other languages
English (en)
Other versions
AU1488092A (en
Inventor
Wenling Kao
John Henry Musser
Robert Lewis Vogel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/686,728 external-priority patent/US5118678A/en
Priority claimed from US07/837,048 external-priority patent/US5194447A/en
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU1488092A publication Critical patent/AU1488092A/en
Application granted granted Critical
Publication of AU642592B2 publication Critical patent/AU642592B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU14880/92A 1991-04-17 1992-04-14 Carbamates of rapamycin Ceased AU642592B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/686,728 US5118678A (en) 1991-04-17 1991-04-17 Carbamates of rapamycin
US686728 1991-04-17
US07/837,048 US5194447A (en) 1992-02-18 1992-02-18 Sulfonylcarbamates of rapamycin
US837048 1997-04-11

Publications (2)

Publication Number Publication Date
AU1488092A AU1488092A (en) 1992-10-22
AU642592B2 true AU642592B2 (en) 1993-10-21

Family

ID=27103855

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14880/92A Ceased AU642592B2 (en) 1991-04-17 1992-04-14 Carbamates of rapamycin

Country Status (12)

Country Link
EP (1) EP0509795A2 (cg-RX-API-DMAC10.html)
JP (1) JPH05112573A (cg-RX-API-DMAC10.html)
KR (1) KR920019798A (cg-RX-API-DMAC10.html)
AU (1) AU642592B2 (cg-RX-API-DMAC10.html)
CZ (1) CZ117392A3 (cg-RX-API-DMAC10.html)
FI (1) FI921595A7 (cg-RX-API-DMAC10.html)
HU (1) HU9201254D0 (cg-RX-API-DMAC10.html)
IE (1) IE921249A1 (cg-RX-API-DMAC10.html)
MX (1) MX9201710A (cg-RX-API-DMAC10.html)
NO (1) NO921449L (cg-RX-API-DMAC10.html)
NZ (1) NZ242367A (cg-RX-API-DMAC10.html)
SK (1) SK117392A3 (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU659452B2 (en) * 1991-05-14 1995-05-18 Wyeth Rapamycin metabolites
AU677321B2 (en) * 1993-04-08 1997-04-17 Novartis Ag Rapamycin assay

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118677A (en) * 1991-05-20 1992-06-02 American Home Products Corporation Amide esters of rapamycin
WO1993018043A1 (en) * 1992-03-05 1993-09-16 American Home Products Corporation Novel rapamycin 42-sulfonates and 42-(n-carboalkoxy)sulfamates useful as immunosuppressive agents
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
US5527907A (en) * 1993-11-19 1996-06-18 Abbott Laboratories Macrolide immunomodulators
WO1995014023A1 (en) * 1993-11-19 1995-05-26 Abbott Laboratories Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ES2377847T3 (es) 1999-01-13 2012-04-02 Bayer Healthcare Llc Difenil ureas sustituidas con omega-carboxi arilo como agentes inhibidores de la cinasa p38
DE60012192T2 (de) * 1999-08-18 2005-09-08 Wyeth Wasserlösliche sdz-rad ester
EP1478358B1 (en) 2002-02-11 2013-07-03 Bayer HealthCare LLC Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
ES2288694T3 (es) 2003-05-20 2008-01-16 Bayer Pharmaceuticals Corporation Diaril ureas para enfermedades mediadas por el receptor del factor de crecimiento derivado de plaquetas.
KR101139557B1 (ko) 2003-07-23 2012-04-30 바이엘 파마슈티칼스 코포레이션 질환 및 상태의 치료 및 예방을 위한 플루오로 치환오메가-카르복시아릴 디페닐 우레아
CA2544731A1 (en) * 2003-11-03 2005-05-12 Altachem Pharma Ltd. Rapamycin peptides conjugates: synthesis and uses thereof
US8021849B2 (en) 2004-11-05 2011-09-20 Siemens Healthcare Diagnostics Inc. Methods and kits for the determination of sirolimus in a sample
EP1856131A1 (en) 2005-03-07 2007-11-21 Wyeth Oxepane isomer of 42-o-(2-hydroxy)ethyl-rapamycin
US7189582B2 (en) 2005-04-27 2007-03-13 Dade Behring Inc. Compositions and methods for detection of sirolimus
MX2021008930A (es) * 2019-01-25 2021-11-04 Nodthera Ltd Derivados de carbamato y sus usos.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1637892A (en) * 1991-05-20 1992-11-26 American Home Products Corporation Amide esters of rapamycin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885171A (en) * 1978-11-03 1989-12-05 American Home Products Corporation Use of rapamycin in treatment of certain tumors
US4316885A (en) * 1980-08-25 1982-02-23 Ayerst, Mckenna And Harrison, Inc. Acyl derivatives of rapamycin
US4650803A (en) * 1985-12-06 1987-03-17 University Of Kansas Prodrugs of rapamycin
AU6286690A (en) * 1989-08-18 1991-04-03 Fisons Plc Macrocyclic compounds
PT98990A (pt) * 1990-09-19 1992-08-31 American Home Prod Processo para a preparacao de esteres de acidos carboxilicos de rapamicina

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1637892A (en) * 1991-05-20 1992-11-26 American Home Products Corporation Amide esters of rapamycin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU659452B2 (en) * 1991-05-14 1995-05-18 Wyeth Rapamycin metabolites
AU677321B2 (en) * 1993-04-08 1997-04-17 Novartis Ag Rapamycin assay

Also Published As

Publication number Publication date
IE921249A1 (en) 1992-10-21
FI921595A0 (fi) 1992-04-10
HU9201254D0 (en) 1992-07-28
NZ242367A (en) 1994-07-26
CZ117392A3 (en) 1993-09-15
NO921449D0 (no) 1992-04-10
JPH05112573A (ja) 1993-05-07
EP0509795A2 (en) 1992-10-21
FI921595L (fi) 1992-10-18
KR920019798A (ko) 1992-11-20
SK117392A3 (en) 1995-04-12
AU1488092A (en) 1992-10-22
EP0509795A3 (cg-RX-API-DMAC10.html) 1994-03-23
MX9201710A (es) 1993-01-01
FI921595A7 (fi) 1992-10-18
NO921449L (no) 1992-10-19

Similar Documents

Publication Publication Date Title
AU642592B2 (en) Carbamates of rapamycin
US5194447A (en) Sulfonylcarbamates of rapamycin
US5118678A (en) Carbamates of rapamycin
US5252579A (en) Macrocyclic immunomodulators
US5120725A (en) Bicyclic rapamycins
US5387680A (en) C-22 ring stabilized rapamycin derivatives
US5177203A (en) Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents
US5100883A (en) Fluorinated esters of rapamycin
EP0730597B1 (en) Heterocyclic esters of rapamycin and pharmaceutical compositions containing them
EP0666861B1 (en) Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
US5233036A (en) Rapamycin alkoxyesters
US5385910A (en) Gem-distributed esters of rapamycin
US5455249A (en) Phosphorylcarbamates of rapamycin and oxime derivatives thereof
JP3725901B2 (ja) ラパマイシンヒドロキシエステル、それらの製造方法、および、それらを含有する医薬組成物
US5489595A (en) Carbamates of rapamycin
US5262424A (en) Composition of sulfonylcarbamates of rapamycin and method of treating diseases requiring immunosuppression therewith
HUT73418A (en) Process for preparing rapamycin carbonate esters and pharmaceutical compositions of immunosuppressive activity containing said compounds
US5260299A (en) Rapamycin 42-sulfonates and 42-(N-Carboalkoxy)Sulfamates Useful as Immunosuppressive Agents
US5349060A (en) Rapamycin 31-ester with N,N-dimethylglycine derivatives useful as immunosuppressive agents
EP0593227B1 (en) Carbamates of rapamycin
JP2009537504A (ja) 癌および他の疾患の治療のための３９−デスメトキシ−３９−メチルラパマイシン誘導体
EP0516347A1 (en) Rapamycin derivatives
KR100304327B1 (ko) 라파마이신의카밤산염및이를포함하는약제학적조성물
HK1011354B (en) Heterocyclic esters of rapamycin and pharmaceutical compositions containing them